Wegovy, Saxenda study reveals surprising trend for weight loss drugs
Saxenda, which requires daily injections, was the only GLP-1 drug ... Drug Administration approval for weight loss in 2021 as a weekly injectable, prescriptions soared, reaching nearly 121,000 ...
Hosted on MSN1mon
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones ... lower than name brand Victoza and Saxenda, but lessons from other drugs that are ...
pharmaphorum4y
Price cut leads NICE to back Novo Nordisk’s obesity drug Saxenda
Novo Nordisk’s Saxenda has been recommended by NICE as ... The company’s GLP-1 agonists for diabetes grew strongly, thanks to its once-weekly injectable Ozempic (semaglutide) which grew ...
pharmaphorum3y
Novo Nordisk nears EU approval of obesity drug Wegovy
Danish drugmaker Novo Nordisk is hoping to launch its once-weekly injectable treatment ... already sells an older, once-daily injectable drug for obesity – Saxenda (liraglutide) – but has ...